Advus Financial Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Advus Financial Partners's PFE Position: Q2 2026 in Review
Advus Financial Partners reduced its Pfizer (PFE) stake by 37% in Q2 2026, selling an estimated $181K and leaving 11,766 shares worth $283K. The position accounts for 0.06% of the portfolio, ranked #202.
Advus Financial Partners first reported a position in PFE in Q3 2021 and has held it in 19 quarters since. The position peaked at $818K in Q4 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Advus Financial Partners held 11,766 shares of Pfizer worth $283K as of Q2 2026.
- Advus Financial Partners sold 6,923 Pfizer shares in Q2 2026, an estimated $181K.
- Pfizer made up 0.06% of Advus Financial Partners's portfolio in Q2 2026, its #202 holding.
- Advus Financial Partners first reported a position in Pfizer in Q3 2021 and has held it in 19 quarters since.
- Advus Financial Partners's Pfizer position peaked at $818K in Q4 2022.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Advus Financial Partners's 13F filing for Q2 2026, filed 25 Aug 2026.